Between doctor’s appointments it is decided whether a chronic illness remains stable – or whether symptoms worsen. Medications are taken irregularly and dietary requirements become irrelevant in everyday life. It is precisely this gap that the Frankfurt healthtech startup Oska Health wants to close – and is now raising 11 million euros in seed capital, as the startup announces.
